Mild Cognitive Impairment

References

Abell CW, Kwan SW. Molecular characterization of monoamine oxidases A and B. Prog Nucleic Acid Res Mol Biol. 2001;65:129–56.

Al-Zuhair H, Abd el-Fattah A, et al. The effect of meclofenoxate with ginkgo biloba extract or zinc on lipid peroxide, some free radical scavengers and the cardiovascular system of aged rats. Pharmacol Res. 1998 Jul;38(1):65–72.

Aleman A, Muller M, et al. Vascular risk factors and cognitive function in a sample of independently living men. Neurobiol Aging. 2005 Apr;26(4):485-90.

Amenta D, Ferrante F, et al. Effects of long-term Hydergine administration on lipofuscin accumulation in senescent rat brain. Gerontology. 1988;34(5–6):250–6.

Amenta F, Tayebati SK, et al. Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: An approach for enhancing cholinergic neurotransmission. Mech Ageing Dev. 2005 Nov 14; [Epub ahead of print].

Ames BN, Liu J. Delaying the mitochondrial decay of aging with acetylcarnitine. Ann NY Acad Sci. 2004 Nov;1033:108–16.

Andres-Laceuva C, Shukitt-Hale B, et al. Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr Neurosci. 2005 Apr;8(2):111–20.

Balestreri R, Fontana L, et al. A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction. J Am Geriatr Soc. 1987 May;35(5):425–30.

Barrett-Connor E, Goodman-Gruen D, et al. Endogenous sex hormones and cognitive function in older men. J Clin Endocrinol Metab. 1999 Oct;84(10):3681–5.

Bartus RT, Dean RL III, et al. Profound effects of combining choline and piracetam on memory enhancement and cholinergic function in aged rats. Neurobiol Aging. 1981;2(2):105–11.

Beers MH, Berkow R, eds. The Merck Manual of Diagnosis and Therapy. 17th ed. Whitehouse Station, N.J.: Merck & Co.; 1999.

Boismare F, Le Poncin M, et al. Biochemical and behavioural effects of hypoxic hypoxia in rats: Study of the protection afforded by ergot alkaloids. Gerontology. 1978;24 Suppl 1:6–13.

Bonavita E. Study of the efficacy and tolerability of acetyl-L-carnitine therapy in the senile brain. Int J Clin Pharmacol Ther Toxicol. 1986;24:511–6.

Busse A, Bischkopf J, et al. Subclassifications for mild cognitive impairment: prevalence and predictive validity. Psychol Med. 2003 Aug;33(6):1029-38.

Cahn J, Borzeix MG. [Cerebral blood flow and metabolism, and neurologic deficit in an experimental infarction: Application to the study of an ergot derivative]. Presse Med. 1983 Dec 29;12(48):3058–60.

Canonico PL, Aronica E, et al. Repeated injections of piracetam improve spatial learning and increase the stimulation of inositol phospholipid hydrolysis by excitatory amino acids in aged rats. Funct Neurol. 1991 Apr;6(2):107–11.

Capurso A, Panza F, et al. Age-related cognitive decline: Evaluation and prevention strategy. Recenti Prog Med. 2000 Mar;91(3):127–34.

Carmel R. Subtle cobalamin deficiency. Ann Intern Med. 1996 Feb 1;124(3):338–40.

Casson P, Faquin L, et al. Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women. Fertil Steril. 1995;63:1027–31.

Corrigan FM, Horrobin DF, et al. Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer’s disease patients and its relationship to acetyl CoA content. Int J Biochem Cell Biol. 1998 Feb;30(2):197–207.

Davis JD, Stern RA, et al. Cognitive and neuropsychiatric aspects of subclinical hypothyroidism: Significance in the elderly. Curr Psychiatry Rep. 2003 Oct;5(5):384–90.

Deijen JB, Van der Beek EJ, et al. Vitamin B-6 supplementation in elderly men: Effects on mood, memory, performance and mental effort. Psychopharmacology (Berl). 1992;109(4):489–96.

Dhuley JN. Nootropic-like effect of ashwagandha (Withania somnifera L.) in mice. Phytother Res. 2001 Sep;15(6):524–8.

Ditch M, Kelly FJ, et al. An ergot preparation (hydergine) in the treatment of cerebrovascular disorders in the geriatric patient: Double-blind study. J Am Geriatr Soc. 1971 Mar;19(3):208–17.

Dorman WB, Cote L, et al. Effects of an extract of Ginkgo biloba on bromethalin-induced cerebral lipid peroxidation and edema in rats. Am J Vet Res. 1992;53(1):138–42.

Dormehl IC, Jordaan B, et al. SPECT monitoring of improved cerebral blood flow during long-term treatment of elderly patients with nootropic drugs. Clin Nucl Med. 1999 Jan;24(1):29–34.

Emmenegger H, Meier-Ruge W. The actions of Hydergine on the brain: A histochemical, circulatory and neurophysiological study. Pharmacology. 1968;1(1):65–78.

Ferrari E, Casarotti D, et al. Age-related changes of the adrenal secretory pattern: Possible role in pathological brain aging. Brain Res Rev. 2001 Nov;37(1–3):294–300.

Ferrari E, Mirani M, et al. Cognitive and affective disorders in the elderly: A neuroendocrine study. Arch Gerontol Geriatr Suppl. 2004;(9):171–82.

Fioravanti MFE. Low folate levels in the cognitive decline of elderly patients and the efficacy of folate as a treatment for improving memory deficits. Arch Gerontol Geriatr. 1997;26(1):1–13.

Fontani G, Corradeschi F, et al. Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J Clin Invest. 2005 Nov;35(11):691-9.

Gaal L, Molnar P. Effect of vinpocetine on noradrenergic neurons in rat locus coeruleus. Eur J Pharmacol. 1990 Oct 23;187(3):537–9.

Gallai V, Mazzotta G, et al. A clinical and neurophysiological trial on nootropic drugs in patients with mental decline. Acta Neurol (Napoli). 1991 Feb;13(1):1-12.

Gebner B, Voelp A, et al. Study of the long-term action of a Ginkgo biloba extract on vigilance and mental performance as determined by means of quantitative pharmaco-EEG and psychometric measurements. Arzneim-Forsch. 1985;35:1459–65.

Goodenough S, Engert S, et al. Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway. Neurosci Lett. 2000 Dec 15;296(1):49–52.

Gouras GK, Xu H, et al. Testosterone reduces neuronal secretion of Alzheimer’s beta-amyloid peptides. Proc Natl Acad Sci USA 2000 Feb 1;97(3):1202–5.

Hadjiev D, Yancheva S. Rheoencephalographic and psychological studies with ethyl apovincaminate in cerebral vascular insufficiency. Arzneimittelforschung. 1976;26(10a):1947–50.

Heiss WD, Hebold I, et al. Effect of piracetam on cerebral glucose metabolism in Alzheimer’s disease as measured by positron emission tomography. J Cereb Blood Flow Metab. 1988 Aug;8(4):613–7.

Heiss WD, Szelies B, et al. Abnormalities of energy metabolism in Alzheimer’s disease studied with PET. Ann N Y Acad Sci. 1991;640:65–71.

Hogervorst E, Williams J, et al. Serum total testosterone is lower in men with Alzheimer’s disease. Neuro Endocrinol Lett. 2001 Jun;22(3):163–8.

Huang P, Feng G, et al. [Effect of Ginkgo biloba L leaves on oxidation of human low density lipoproteins in vitro]. Wei Sheng Yan Jiu. 2004a Jul;33(4):453–4, 2 p following 520.

Huang P, Li J, et al. [Comparison study on inhibitory effect of extracts from leaves of Ginkgo biloba L. on the oxidation of human low density lipoproteins]. Zhong Yao Cai. 2004b Sep;27(9):654–6.

Joseph JA, Denisova NA, et al. Oxidative stress protection and vulnerability in aging: Putative nutritional implications for intervention. Mech Ageing Dev. 2000 Jul 31;116(2–3):141–53.

Joseph JA, Denisova NA, et al. Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci. 2003 Jun;6(3):153–62.

Joseph JA, Shukitt-Hale B, et al. Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits. J Neurosci. 1998;18(19):8047–55.

Kalmijn S, Launer LJ, et al. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol. 1997;42(5):776–82.

Kar A, Panda S, et al. Relative efficacy of three medicinal plant extracts in the alteration of thyroid hormone concentrations in male mice. J Ethnopharmacol. 2002 Jul;81(2):281–5.

Karasek M. Melatonin, human aging, and age-related diseases. Exp Gerontol. 2004 Nov-Dec;39(11–12):1723–29.

Karlamangla AS, Singer BH, et al. Increase in epinephrine excretion is associated with cognitive decline in elderly men: MacArthur studies of successful aging. Psychoneuroendocrinology. 2005 Jun;30(5):453-60.

Kidd PM. A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Altern Med Rev. 1999 Jun;4(3):144–61.

Kitajka K, Sinclair AJ, et al. Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):10931-6.

Koc R, Akdemir H, et al. Lipid peroxidation in experimental spinal cord injury: Comparison of treatment with Ginkgo biloba, TRH and methylprednisone. Res Esp Med (Berlin). 1995;195(2):117–23.

Koistinaho M, Koistinaho J. Interactions between Alzheimer's disease and cerebral ischemia--focus on inflammation. Brain Res Brain Res Rev. 2005 Apr;48(2):240-50. Epub 2005 Jan 18. Review.

Lau FC, Shukitt-Hale B, et al. The beneficial effects of fruit polyphenols on brain aging. Neurobiol Aging. 2005 Dec;26 Suppl 1:128–32.

Le Bars PL, Kastelan J. Efficacy and safety of a Ginkgo biloba extract. Pub Health Nutr. 2000;3(4A):495–9.

Likuw WJ, Cui JG, et al. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest. 2005 Oct;115(10):2774–83.

Low LF, Brodaty H, et al. The prevalence of "cognitive impairment no dementia" in community-dwelling elderly: a pilot study. Aust N Z J Psychiatry. 2004 Sep;38(9):725-31.

Luboshitzky R, Oberman AS, et al. Prevalence of cognitive dysfunction and hypothyroidism in an elderly community population. Isr J Med Sci. 1996 Jan;32(1):60-5.

Lustyik G, Nagy I. Alterations of the intracellular water and ion concentrations in brain and liver cells during aging as revealed by energy dispersive X-ray microanalysis of bulk specimens. Scan Electron Microsc. 1985;(Pt 1):323–37.

Markstein R. Hydergine: Interaction with the neurotransmitter systems in the central nervous system. J Pharmacol. 1985;16 Suppl 3:1–17.

Matthews RT, Yang L, et al. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8892–7.

Mayo W, Le Moal M, et al. Pregnenolone sulfate and aging of cognitive functions: Behavioral, neurochemical, and morphological investigations. Horm Behav. 2001 Sep;40(2):215–7.

McCann JC, Ames BN. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr. 2005 Aug;82(2):281–95.

McDaniel MA, Maier SF, et al. “Brain-specific” nutrients: A memory cure? Nutrition. 2003 Nov-Dec;19(11–12):957–75.

Moger WH. In vitro inhibitory effect of estradiol on testosterone production. J Steroid Biochem. 1980 Jan;13(1):61–6.

Moriguchi T, Salem N Jr. Recovery of brain docosahexaenoate leads to recovery of spatial task performance. J Neurochem. 2003 Oct;87(2):297–309.

Nagasawa H, Kogure K, et al. Effects of co-dergocrine mesylate (Hydergine) in multi-infarct dementia as evaluated by positron emission tomography. Tohoku J Exp Med. 1990 Nov;162(3):225–33.

Naoi M, Maruyama W, et al. Anti-apoptotic function of L-(-)deprenyl (Selegiline) and related compounds. Neurobiology (Bp). 2000;8(1):69–80.

Nosalova V, Machova J, et al. Protective action of vinpocetine against experimentally induced gastric damage in rats. Arzneimittelforschung. 1993 Sep;43(9):981–5.

Olin J, Schneider L, et al. Hydergine for dementia. Cochrane Database Syst Rev. 2001;(2):CD000359. Review.

Orru S, Mascia V, et al. Association of monoamine oxidase B alleles with age at onset in amyotrophic lateral sclerosis. Neuromuscul Disord. 1999 Dec;9(8):593–7.

Panza F, Solfrizzi V, et al. Mediterranean diet and cognitive decline. Public Health Nutr. 2004 Oct;7(7):959–63.

Parnetti L, Amenta F, Gallai V. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data. Mech Ageing Dev. 2001 Nov;122(16):2041-55.

Passeri M, Cucinotta D, et al. Acetyl-L-carnitine in the treatment of mildly demented elderly patients. Int J Clin Pharmacol Res. 1990;10(1–2):75–79.

Patro N, Sharma SP, et al. Lipofuscin accumulation in ageing myocardium & its removal by meclophenoxate. Indian J Med Res. 1992 Jun;96:192–8.

Pereira C, Agostinho P, et al. Vinpocetine attenuates the metabolic dysfunction induced by amyloid beta-peptides in PC12 cells. Free Radic Res. 2000 Nov;33(5):497–506.

Perrig WJ, Perrig P, et al. The relation between antioxidants and memory performance in the old and very old. J Am Geriatr Soc. 1997 Jun;45(6):718–24.

Petkov VV, Kehayov R, et al. Memory effects of standardized extracts of Panax ginseng (G115), Ginkgo biloba (GK501), and their combination Gincosan (PHL-00701). Planta Medica. 1993;59:106–14.

Pike CJ. Testosterone attenuates beta-amyloid toxicity in cultured hippocampal neurons. Brain Res. 2001 Nov 16;919(1):160–5.

Porrino LJ, Daunais JB, et al. Facilitation of task performance and removal of the effects of sleep deprivation by an ampakine (CX717) in nonhuman primates. PLoS Biol. 2005 Sep;3(9):e299. Epub 2005 Aug 23.

Pragina LL, Voronina TA, et al. [The effect of piracetam and nicergoline on conditioned-reflex memory under conditions of extreme exposure] Farmakol Toksikol. 1990 May-Jun;53(3):8-10.

Qian ZN, Gu ZL, et al. [Effects of piracetam on Na(+)-K(+)-ATPase and monoamine oxidase in rat brain and its antioxidation effect]. Zhongguo Yao Li Xue Bao. 1992 Jan;13(1):48–50.

Rabkin JG, Wagner GJ, et al. Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism. J Clin Psychopharmacol. 1999 Feb;19(1):19–27.

Racchi M, Govoni S, et al. DHEA and the relationship with aging and memory: A possible link with protein kinase C functional machinery. Brain Res Brain Res Rev. 2001 Nov;37(1–3):287–93.

Rai G, Wright G, et al. Double-blind, placebo-controlled study with acetyl-L-carnitine in patients with Alzheimer’s dementia. Curr Med Res Opin. 1990;11:638–47.

Roodenrys S, Booth D, et al. Chronic effects of Brahmi (Bacopa monnieri) on human memory. Neuropsychopharmacology. 2002 Aug;27(2):279–81.

Russo A, Izzo AA, et al. Free radical scavenging capacity and protective effect of Bacopa monniera L. on DNA damage. Phytother Res. 2003 Sep;17(8):870-5.

Santos MS, Duarte AI, et al. Synaptosomal response to oxidative stress: Effect of vinpocetine. Free Radic Res. 2000 Jan;32(1):57–66.

Schindler AE. Thyroid function and postmenopause. Gynecol Endocrinol. 2003 Feb;17(1):79-85. Review.

Schreiber S, Kampf-Sherf O, et al. An open trial of plant-source derived phosphatydilserine for treatment of age-related cognitive decline. Isr J Psychiatry Relat Sci. 2000;37(4):302–7.

Schweiger U, Deuschle M, et al. Testosterone, gonadotropin, and cortisol secretion in male patients with major depression. Psychosom Med. 1999 May-Jun;61(3):292–6.

Scorziello A, Meucci O, et al. Acetyl-L-carnitine arginine amide prevents beta 25–35-induced neurotoxicity in cerebellar granule cells. Neurochem Res. 1997 Mar;22(3):257–65.

Seidman SN, Walsh BT. Testosterone and depression in aging men. Am J Geriatr Psychiatry. 1999;7(1):18–33.

Senin U, Abate G, et al. Aniracetam (Ro 13–5057) in the treatment of senile dementia of Alzheimer type (SDAT): Results of a placebo controlled multicenter clinical study. Eur Neuropsychopharmacol. 1991 Dec;1(4):511–7.

Sharma D, Singh R. Centrophenoxine activates acetylcholinesterase activity in hippocampus of aged rats. Indian J Exp Biol. 1995 May;33(5):365–8.

Solfrizzi V, D’Introno A, et al. Dietary fatty acids intake: Possible role in cognitive decline and dementia. Exp Gerontol. 2005 Apr;40(4):257–70.

Solfrizzi V, Panza F, et al. High monounsaturated fatty acids intake protects against age-related cognitive decline. Neurology. 1999 May 12;52(8):1563–9.

Solfrizzi V, Panza F, et al. The role of diet in cognitive decline. J Neural Transm. 2003 Jan;110(1):95–110.

Sozmen EY, Kanit L, et al. Possible supportive effects of co-dergocrine mesylate on antioxidant enzyme systems in aged rat brain. Eur Neuropsychopharmacol. 1998 Feb;8(1):13–6.

Stancheva SL, Petkov VD, et al. Effects of the nootropic agents adafenoxate and meclofenoxate on brain biogenic monoamines in aged rats. Acta Physiol Pharmacol Bulg. 1988;14(1):14–21.

Stough C, Lloyd J, et al. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology (Berlin). 2001 Aug;156(4):481–4.

Taglialatela G, Navarra D, et al. Neurite outgrowth in PC12 cells stimulated by acetyl-L-carnitine arginine amide. Neurochem Res. 1995 Jan;20(1):1–9.

Tan RS, Pu SJ. The andropause and memory loss: Is there a link between androgen decline and dementia in the aging male? Asian J Androl. 2001 Sep;3(3):169–74.

Tariska P, Paksy A. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia]. Orv Hetil. 2000 May 28;141(22):1189-93.

Thomas T. Monoamine oxidase-B inhibitors in the treatment of Alzheimer’s disease. Neurobiol Aging. 2000 Mar;21(2):343–8.

Tohda C, Kuboyama T, et al. Dendrite extension by methanol extract of Ashwagandha (roots of Withania somnifera) in SK-N-SH cells. Neuroreport. 2000 Jun 26;11(9):1981–5.

Tohda C, Kuboyama T, et al. Search for natural products related to regeneration of the neuronal network. Neurosignals. 2005;14(1–2):34–45.

Turner N, Else PL, et al. Docosahexaenoic acid (DHA) content of membranes determines molecular activity of the sodium pump: implications for disease states and metabolism. Naturwissenschaften. 2003 Nov;90(11):521-3.

VonDras DD, Powless MR, et al. Differential effects of everyday stress on the episodic memory test performances of young, mid-life, and older adults. Aging Ment Health. 2005 Jan;9(1):60–70.

Vorberg G. Ginkgo biloba extract (GBE): A long-term study of chronic cerebral insufficiency in geriatric patients. Clin Trials J. 1985;22:149–57.

Weill-Engerer S, David JP, et al. Neurosteroid quantification in human brain regions: Comparison between Alzheimer’s and nondemented patients. J Clin Endocrinol Metab. 2002 Nov;87(11):5138–43.

Wesnes KA, Ward T, et al. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology (Berlin). 2000;152(4):353–61.

Wood WG, Gorka C, et al. Fluidizing effects of centrophenoxine in vitro on brain and liver membranes from different age groups of mice. Life Sci. 1986 Dec 1;39(22):2089–95.

Wright AS, Douglas RC, et al. Androgen-induced regrowth in the castrated rat ventral prostate: Role of 5alpha-reductase. Endocrinology. 1999 Oct;140(10):4509–15.

Xu SS, Gao ZX, et al. Efficacy of tablet Huperzine A on memory, cognition, and behavior in Alzheimer’s disease. Chung Kuo Yao Ki Hsueh Pao. 1995;16:391–5.

Yaffe K, Ettinger B, et al. Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: A prospective study. Biol Psychiatry. 1998 May 1;43(9):694–700.

Yen S, Morales A, et al. Replacement of DHEA in aging men and women: Potential remedial effects. Ann NY Acad Sci. 1995;774:128–42.

Yoshikawa T, Naito Y, et al. Ginkgo biloba leaf extract: Review of biological actions and clinical applications. Antioxid Redox Signal. 1999;1(4):469–80.

Zhang RW, Tang XC, et al. Drug evaluation of Huperzine A in the treatment of senile memory disorders. Chung Kuo Yao Ki Hsueh Pao. 1991;12:250–2.

Zs-Nagy I. On the role of intracellular physicochemistry in quantitative gene expression during aging and the effect of centrophenoxine: A review. Arch Gerontol Geriatr. 1989 Nov;9(3):215–29.